Prognosis
US Buys More Monkeypox Vaccine, Ramps Up Testing as Cases Rise
- 2.5 million more Jynneos doses will be ready in 2023, HHS says
- Testing capacity has increased from 6,000 to 70,000 per week
This article is for subscribers only.
The US has ordered another 2.5 million doses of Bavarian Nordic A/S’s Jynneos vaccine that will be available next year as monkeypox continues to spread with more than 1,400 cases reported nationally as of Friday.
The Centers for Disease Control and Prevention expects more infections to be reported in coming days as the government has greatly expanded testing to include several commercial labs, Director Rochelle Walensky said in a press call. The US can now test 70,000 samples a week, up from 6,000, she said.